DUBLIN--(BUSINESS WIRE)--The "Global Antifungal Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The antifungal drugs market is projected to register a CAGR of over 3% by 2022.
Use of antifungal infections is expected to drive growth in the market
Research has shown synergism between many antifungals, which has led to an increase in clinicians prescribing combination therapies over monotherapies. Also, availability of antifungals with novel mechanisms of actions has promoted the trend of using combinations.
Increase in antifungal research funding
An increase in funding for antifungal research is another key factor contributing to the growth of the global antifungal drugs market. In many European countries, government funding is also available for research in fungal diseases.
Diagnostic challenges due to non-specific symptoms
Antifungals are often associated with mild adverse effects like itching, redness, abdominal pain, and diarrhea.
Key Players
- Astellas Pharma
- Basilea Pharmaceutica
- Merck
- Pfizer
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: PIPELINE ANALYSIS
PART 06: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
PART 08: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION
- Segmentation by route of administration
- Comparison by route of administration
- Topical - Market size and forecast 2017-2022
- Oral - Market size and forecast 2017-2022
- Parenteral - Market size and forecast 2017-2022
- Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Vendors covered
PART 15: VENDOR ANALYSIS
- Market positioning of vendors
- Astellas Pharma
- Basilea Pharmaceutica
- Merck
- Pfizer
For more information about this report visit https://www.researchandmarkets.com/research/6x3cx8/worldwide?w=4
